Coagulation Derangements in Oral and Maxillofacial Surgery in Patients with a Documented Cancer: a Follow-up Study after Surgery

Abstract

Get full access to this article

View all access options for this article.

References

Ames PRJ, Pyke S, Iannaccone L, Brancaccio V -1995-. Antiphospholipid antibodies, haemostatic variables and thrombosis. A survey of 144 patients. Thromb Haemostas 73:768–773.

Dahlback B -1994-. Physiological anticoagulation. Resistance to active protein C and venous thromboembolism. J Clin Invest 94:923–927.

Di Micco P, De Lucia D, De Vita F, Niglio A, Di Micco G, Martinelli E, et al. -2002-. Acquired cancer-related thrombophilia testified by increased levels of prothrombin fragment 1+2 and D-dimer in patients affected by solid tumors. Exp Oncol 24:108–111.

Furie B, Furie CB -1992-. Molecular and cellular biology of blood coagulation. New Eng J Med 326:800–806.

Lowry JC -1995-. Thromboembolic disease and thromboprophylaxis in oral and maxillofacial surgery: experience and practice. Br J Oral Maxillofac Surg 33:101–106.

Malm J, Laurell M, Nilsson IM, Dahlback B -1992-. Thromboembolic disease. Critical evaluation of laboratory investigation. Thromb Haemostas 68:7–13.

Miletich JP, Prescott SM, White R, Majerus PW, Bovill EG -1993-. Inherited predisposition to thrombosis. Cell 72:477–480.

Schaper AI -1994-. Hypercoagulable states: from molecular genetics to clinical practice. Lancet 344:1739–1742.